LAS VEGAS, May 12, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX), announced today that it will exhibit the Company at the upcoming MoneyShow in Las Vegas, which will be held from May 12-15th at Caesar's Palace Hotel. Chief Executive Officer, Craig Ellins, will present details about the Company as well as industry insights regarding the advancement of the medical cannabis industry. Mr. Ellins will be speaking on Wednesday, May 14th at 2:15 p.m.
Investors are welcome to visit the GrowBLOX Sciences booth, #702, in the Exhibit Hall. Admission is free and can be obtained at www.moneyshow.com.
"We believe exhibiting at this premier conference is an excellent opportunity to showcase the Company and to meet and network with hundreds of qualified investors, equity traders, and finance professionals," said Craig Ellins, Chief Executive Officer of GrowBLOX Sciences. "We are looking forward to sharing our latest developments in medical cannabis cultivation technology and news on our Company's direction."
For over 30 years, The MoneyShow has been a global, financial media company known as a leading producer of investment tradeshows, as well as producer of the award-winning, multimedia online community, www.MoneyShow.com, and interactive eShows. The MoneyShow gathers qualified investors, traders, and financial advisors, representing billions in investment assets, providing them access to the world's leading financial experts, business, and media professionals. The MoneyShow has partnerships with leading financial media companies; such as Forbes, Barron's, Morningstar, CNBC, Investor's Business Daily, and Better Investing.
Top Wall Street investment and trading experts attract investors to the MoneyShow who are eager to learn about investing in public companies and to gain access to their professional advice and buy-and-hold strategies.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01
SOURCE GrowBLOX Sciences, Inc.